DataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe Compute
DataMEDS AI has acquired Helomics Corporation, an AI cancer diagnostics lab and precision oncology CRO business, from Axe Compute for $1.5 million in common shares and an acquisition note.
Why it matters — The sale of Helomics for a relatively modest $1.5 million indicates Axe Compute is divesting a subsidiary, potentially to raise operational capital or streamline its focus on its core neocloud AI infrastructure business.